Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
14 clinical trials · Sponsor
◉ Watch Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia (NCT05011669) | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2021-08-16 |
| Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients (NCT03784222) | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2019-01-22 |
Track Marubeni Pharmaceuticals (Suzhou) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.